AMOT suppresses tumor progression via regulating DNA damage response signaling in diffuse large B-cell lymphoma
出版年份 2021 全文链接
标题
AMOT suppresses tumor progression via regulating DNA damage response signaling in diffuse large B-cell lymphoma
作者
关键词
-
出版物
CANCER GENE THERAPY
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2021-01-08
DOI
10.1038/s41417-020-00258-5
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Sirt6 promotes tumorigenesis and drug resistance of diffuse large B-cell lymphoma by mediating PI3K/Akt signaling
- (2020) Juan Yang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Regulation of Hippo-YAP signaling by insulin-like growth factor-1 receptor in the tumorigenesis of diffuse large B-cell lymphoma
- (2020) Xiangxiang Zhou et al. Journal of Hematology & Oncology
- Angiomotin-p130 inhibits β-catenin stability by competing with Axin for binding to tankyrase in breast cancer
- (2019) Jiao Yang et al. Cell Death & Disease
- The BRUCE-ATR Signaling Axis Is Required for Accurate DNA Replication and Suppression of Liver Cancer Development
- (2019) Chunmin Ge et al. HEPATOLOGY
- Novel CHK1 inhibitor MU380 exhibits significant single-agent activity in TP53-mutated chronic lymphocytic leukemia cells
- (2019) Miroslav Boudny et al. HAEMATOLOGICA
- AMOT is required for YAP function in high glucose induced liver malignancy
- (2018) Ya Liu et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- YAP1-Mediated Suppression of USP31 Enhances NFκB Activity to Promote Sarcomagenesis
- (2018) Shuai Ye et al. CANCER RESEARCH
- AmotP130 regulates Rho GTPase and decreases breast cancer cell mobility
- (2018) Zhe-Ling Chen et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- The physiological role of Motin family and its dysregulation in tumorigenesis
- (2018) Tingting Huang et al. Journal of Translational Medicine
- Management of relapsed/refractory DLBCL
- (2018) Clémentine Sarkozy et al. BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
- Angiomotins stimulate LATS kinase autophosphorylation and act as scaffolds that promote Hippo signaling
- (2018) Sebastian Mana-Capelli et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Gestational age-related patterns of AMOT methylation are revealed in preterm infant endothelial progenitors
- (2017) Giovanna Vinci et al. PLoS One
- Tankyrase Inhibitor Sensitizes Lung Cancer Cells to Endothelial Growth Factor Receptor (EGFR) Inhibition via Stabilizing Angiomotins and Inhibiting YAP Signaling
- (2016) Hui Wang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- PKCι regulates nuclear YAP1 localization and ovarian cancer tumorigenesis
- (2016) Y Wang et al. ONCOGENE
- MicroRNA-497 inhibits cell proliferation, migration, and invasion by targeting AMOT in human osteosarcoma cells
- (2016) Wendong Ruan et al. OncoTargets and Therapy
- Angiomotin is a novel component of cadherin-11/β-catenin/p120 complex and is critical for cadherin-11-mediated cell migration
- (2015) Angelica Ortiz et al. FASEB JOURNAL
- NF-κB-dependent DNA damage-signaling differentially regulates DNA double-strand break repair mechanisms in immature and mature human hematopoietic cells
- (2015) D Kraft et al. LEUKEMIA
- Tankyrase Inhibitors Target YAP by Stabilizing Angiomotin Family Proteins
- (2015) Wenqi Wang et al. Cell Reports
- Diffuse large B-cell lymphoma: optimizing outcome in the context of clinical and biologic heterogeneity
- (2014) Laurie H. Sehn et al. BLOOD
- Angiomotin decreases lung cancer progression by sequestering oncogenic YAP/TAZ and decreasing Cyr61 expression
- (2014) Y-L Hsu et al. ONCOGENE
- Overexpression of angiomotin in sinonasal inverted papilloma
- (2014) Jang Yul Byun et al. International Forum of Allergy & Rhinology
- Proteomic identification of angiomotin by ProteomeLab PF-2D and correlation with clinical outcome in human clear cell renal cell carcinoma
- (2013) JIN YANG et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Actin-binding and Cell Proliferation Activities of Angiomotin Family Members Are Regulated by Hippo Pathway-mediated Phosphorylation
- (2013) Siew Wee Chan et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Diffuse large B-cell lymphoma—treatment approaches in the molecular era
- (2013) Mark Roschewski et al. Nature Reviews Clinical Oncology
- Serum deprivation inhibits the transcriptional co-activator YAP and cell growth via phosphorylation of the 130-kDa isoform of Angiomotin by the LATS1/2 protein kinases
- (2013) J. J. Adler et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Targeting radiation-resistant hypoxic tumour cells through ATR inhibition
- (2012) I M Pires et al. BRITISH JOURNAL OF CANCER
- Tankyrase-targeted therapeutics: expanding opportunities in the PARP family
- (2012) Jenna L. Riffell et al. NATURE REVIEWS DRUG DISCOVERY
- A Tight Junction-Associated Merlin-Angiomotin Complex Mediates Merlin's Regulation of Mitogenic Signaling and Tumor Suppressive Functions
- (2011) Chunling Yi et al. CANCER CELL
- The Adaptor Protein AMOT Promotes the Proliferation of Mammary Epithelial Cells via the Prolonged Activation of the Extracellular Signal-Regulated Kinases
- (2011) W. P. Ranahan et al. CANCER RESEARCH
- Structural Basis and Sequence Rules for Substrate Recognition by Tankyrase Explain the Basis for Cherubism Disease
- (2011) Sebastian Guettler et al. CELL
- Angiomotin is a novel Hippo pathway component that inhibits YAP oncoprotein
- (2011) B. Zhao et al. GENES & DEVELOPMENT
- Discovery of Potent and Selective Inhibitors of Ataxia Telangiectasia Mutated and Rad3 Related (ATR) Protein Kinase as Potential Anticancer Agents
- (2011) Jean-Damien Charrier et al. JOURNAL OF MEDICINAL CHEMISTRY
- Selective killing of ATM- or p53-deficient cancer cells through inhibition of ATR
- (2011) Philip M Reaper et al. Nature Chemical Biology
- Focus on histone variant H2AX: To be or not to be
- (2010) Jingsong Yuan et al. FEBS LETTERS
- Death by releasing the breaks: CHK1 inhibitors as cancer therapeutics
- (2010) Cynthia X. Ma et al. TRENDS IN MOLECULAR MEDICINE
- An Oncogene-Induced DNA Damage Model for Cancer Development
- (2008) T. D. Halazonetis et al. SCIENCE
- Differential roles of p80- and p130-angiomotin in the switch between migration and stabilization of endothelial cells
- (2007) Mira Ernkvist et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now